David Schumann discusses the difference between hype-based spikes and price corrections, and how it should inform your decision to sell.

Jason Alt looks at the out-of-control hype that followed close on the heals of the PT, the Pro Tour itself, and results from SCG St. Louis.

After two months of columns, Sylvain looks back to see how his specs have fared and how PT Valencia has affected Modern prices.

We might have seen a record number of 100%+ gainers last week thanks to Pro Tour Valencia. Sigmund looks at which price jumps will stick and which are destined to retrace back down.

Somehow our Insider team knew he was on this deck about an hour before the rest of the Internet. What a brew….

As transcribed from Deck Tech coverage on the PTBNG stream!

MTGO Player of the Year Paul Nemeth has a Bitterblossom Brew that’s neither Faeries nor B/x Tokens, yet can still kill an opponent out of nowhere. Could this be the new home of the recently unbanned Enchantment?

With the Modern Pro Tour right around the corner, Corbin looks at relevant spec targets, some sure-fire and some more speculative.

Standard appears stagnant and unlikely to yield exciting spec opportunities right now, while Modern is ripe as ever for gains. Sigmund explains his current strategy.

Matthew Lewis believes the MTGO market has overreacted to the B&R announcement with its pricing of Liliana of the Veil. He explains why.

Ryan ruminates on the direction Modern might head in the coming months.

David Schumann outlines some MTG investment basics, explains the concept of discounted cash flow, and asks how the recent B&R announcement will affect Modern.